Clinical TrialID 7231

Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants

NCT04978298

Healthy Volunteers

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7231
Evidence Id
7231
Core Evidence Id
7231
Source Clinical Trial Id
7221
Herb2 Clinical Trial Id
HBCT007221
Nct Id
NCT04978298
Title
Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Healthy Volunteers
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
OTHER: Placebo|DRUG: Rasigiline|DRUG: Phenelzine|DRUG: Ozanimod
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Adult
Enrollment
128
Outcome Measure
Tyramine Sensitivity Factor (TSF), The ratio of Tyramine pressor response (Tyr30) in Period 1 over Tyr30 in Period 3., Up to Day 85
Sponsor Collaborator
Celgene
Funded By
INDUSTRY
Location
Local Institution - 001, Anaheim, California, 92801, United States
Other Id
RPC-1063-CP-005
Start Date
2021-07-19
Primary Completion Date
2023-02-26
Completion Date
2023-02-26
First Posted
2021-07-27
Results First Posted
Last Update Posted
2023-08-31
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04978298
Title Cn
Title En
Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants
Bilingual Status
semi_complete